Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong

Scandinavian Journal of Rheumatology

Volumn 31, Issue 5, 2002, Pages 296-300

  Tam, Lai Shan ^a   Li, Edmund K ^a   Wong, Shiu Man ^a   Szeto, Cheuk Chun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chinese; Systemic lupus erythematosus; Tuberculosis (TB)

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETHAMBUTOL; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; ISONIAZID; METHYLPREDNISOLONE; OFLOXACIN; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; STEROID; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG PULSE THERAPY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HONG KONG; HUMAN; LIVER TOXICITY; LUNG TUBERCULOSIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NAUSEA; ORGANIC BRAIN SYNDROME; PREVALENCE; PRIORITY JOURNAL; RASH; RECURRENT INFECTION; RISK FACTOR; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; TUBERCULOSIS; VASCULITIS; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCOCORTICOIDS; HONG KONG; HUMANS; IMMUNOCOMPROMISED HOST; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NEPHRITIS; PREDNISOLONE; RISK FACTORS; TUBERCULOSIS, MILIARY; TUBERCULOSIS, PULMONARY;

EID: 0036032366     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097402760375205     Document Type: Article

References (30)

1. Petri M. Infection in systemic lupus erythematosus. Rheum Dis Clin North Am 1998;24:423-56.
2. Paton NI. Infections in systemic lupus erythematosus patients. Ann Acad Med Singapore 1997;26:694-700.
3. Feng PH, Tan TH. TB in patients with systemic lupus erythematosus. Ann Rheum Dis 1982;41:11-4.
4. Janwityanuchit S, Totemchokchyakarn K, Krachangwongchai K, Vatanasuk M. Infection in systemic lupus erythematosus. J Med Assoc Thai 1993;76:542-8.
5. Shyam C, Malaviya AN. Infection-related morbidity in systemic lupus erythematosus: A clinico-epidemiological study from northern India. Rheumatol Int 1996;16:1-3.
6. Balakrishnan C, Mangat G, Mittal G, Joshi VR. TB in patients with systemic lupus erythematosus. J Assoc Physicians India 1998;46:682-3.
7. Kim HA, Yoo CD, Baek HJ, Lee EB, Ahn C, Han JS, et al. Mycobacterium TB infection in a corticosteroid-treated rheumatic disease patient population. Clin Exp Rheumatol 1998;16:9-13.
8. Hernandez CB, Sifuentes OJ, Ponce-de-Leon RS, Ponce-deLeon GA, Diaz JE. Mycobacterium TB infection in patients with systemic rheumatic diseases. Clin Exp Rheumatol 1999; 17:289-96.
9. Victorio-Navarra ST, Dy EE, Arroyo CG, Torralba TP. TB among Filipino patients with systemic lupus erythematosus. Semin Arthritis Rheum 1996;26:628-34.
10. Kim HY, Im JG, Goo JM, Lee JK, Song JW, Kim SK. Pulmonary TB in patients with systemic lupus erythematosus. Am J Roentgenol 1999;173:1639-42.
11. Kochi A. The global TB situation and the new control strategy of the World Health Organization 1991. Bull World Health Organ 2001;79:71-5.
12. Chan JC, So SY, Lam WK, Ip MS. High incidence of pulmonary TB in the non-HIV infected immunocompromised patients in Hong Kong. Chest 1989;96:835-9.
13. Hong Kong Chest Service/British Medical Research Council. Survey of patients presenting to the government chest service in Hong Kong and the effects of active TB case-finding by publicity campaigns. Tubercle 1984;65:173-84.
14. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
15. Department of Health Hong Kong, China. Public Health & Epidemiology Bulletin. Available at http://www.info.gov.hk/dh/diseases/diseases/dis_2000.htm.
16. Kwan SY, Yew WW, Chan SL. Nosocomial TB in hospital staff. The size of the problem in a Hong Kong chest hospital. Chin Med J (Engl) 1990;103:909-14.
17. Collazos J, Guerra E, Mayo J, Martinez E. TB as a cause of recurrent fever of unknown origin. J Infect 2000;41:269-72.
18. Nisar M, Williams CS, Davies PD. Experience of TB in immigrants from South East Asia - Implications for the imminent lease back of Hong Kong. Respir Med 1991;85:219-22.
19. Cisneros JR, Murray KM. Corticosteroids in TB. Ann Pharmacother 1996;30:1298-303.
20. Hernandez-Cruz B, Ponce-de-Leon-Rosales S, Sifuentes-Osornio J, Ponce-de-Leon-Garduno A, Diaz-Jouanen E. TB prophylaxis in patients with steroid treatment and systemic rheumatic diseases. A case-control study. Clin Exp Rheumatol 1999;17:81-7.
21. Gaitonde S, Pathan E, Sule A, M ttal G, Joshi VR. Efficacy of isoniazid prophylaxia in patients with systemic lupus erythematosus receiving long term steroid treatment. Ann Rheum Dis 2002;61:251-3.
22. Salpeter SR, Sanders GD, Salpeter EE, Owens DK. Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: A risk-benefit and cost-effectiveness analysis. Ann Intern Med 1997;127:1051-61.
23. Maclntyre CR, Ansari MZ, Carnie J, Hart WG. No evidence for multiple-drug prophylaxis for TB compared with isoniazid alone in Southeast Asian refugees and migrants: Completion and compliance are major determinants of effectiveness. Prev Med 2000;30:425-32.
24. Kammer GM. Impaired T cell capping and receptor regeneration in active systemic lupus erythematosus. Evidence for a disorder intrinsic to the T lymphocyte. J Clin Invest 1983;72:1686-97.
25. Yu CL, Chang KL, Chiu CC, Chiang BN, Han SH, Wang SR. Defective phagocytosis, decreased tumour necrosis factor-alpha production, and lymphocyte hyporesponsiveness predispose patients with systemic lupus erythematosus to infections. Scand J Rheumatol 1989;18:97-105.
26. Tesar V, Jirsa M Jr, Zima T, Kalousova M, Bartunkova J, Stejskalova A, et al. Soluble cytokine receptors in renal vasculitis and lupus nephritis. Med Sci Monit 2002;8:BR24-9.
27. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104.
28. Mayordomo L, Marenco JL, Gomez-Mateos J, Rejon E. Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment. Scand J Rheumatol 2002;31:44-5.
29. Davies P, Grange J. The genetics of host resistance and susceptibility to tuberculosis. Ann N Y Academic Sci 2001;9:151-6.
30. Ozaki Y, Nomura S, Nagahama M, Yoshimura C, Kagawa H, Fukuhara S. Vitamin-D receptor genotype and renal disorder in Japanese patients with systemic lupus erythematosus. Nephron 2000;85:86-91.